REQUEST A DEMO
Total
USD $0.00
Search more companies

Konark Intelmed Tov (Ukraine)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Konark Intelmed Tov Profile Updated: September 09, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Russian Download a sample report

Konark Intelmed Tov is an enterprise in Ukraine, with the main office in Kharkiv. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. Konark Intelmed Tov was incorporated on November 19, 1997. It currently has a total number of 121 (2024) employees. In its most recent financial highlights, the company reported a net sales revenue drop of 30.76% in Q12026. There was a total growth of 25% in Konark Intelmed Tov’s total assets over the same period. Konark Intelmed Tov’s net profit margin increased by 0.42% in 2026.

Headquarters
315 Vul. Shevchenka
Kharkiv; Kharkiv Oblast; Postal Code: 61033

Contact Details: Purchase the Konark Intelmed Tov report to view the information.

Website: http://www.konark.com.ua

Basic Information
Total Employees:
Purchase the Konark Intelmed Tov report to view the information.
Registered Capital:
Purchase the Konark Intelmed Tov report to view the information.
Financial Auditors:
Purchase the Konark Intelmed Tov report to view the information.
Incorporation Date:
November 19, 1997
Key Executives
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Konark Intelmed Tov report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency UAH. Absolute financial data is included in the purchased report.
Net sales revenue
-30.76%
Total Operating Revenue
-29.77%
Operating Profit
21.88%
EBITDA
18.32%
Net Profit/Loss for the Period
-8.28%
Total Assets
25%
Total Equity
8.78%
Operating Profit Margin
1.44%
Net Profit Margin
0.42%
Return on Equity (ROE)
-1.23%
Debt / Equity
57.51%
Quick Ratio
-0.08%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?